Appili Therapeutics Inc.
APLI.TO
TSX
Corporate Info
902-442-4655
#21-1344 Summer Street
Halifax, NS B3H 0A8
Halifax, NS B3H 0A8
Canada
2015
Details
Health Care
Pharmaceuticals, Biotechnology and Life Sciences
9
Business Decription
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.